November 2022
NCI Tech Opportunity Webinar: “New Gene Therapy Method for Treating CRX-autosomal Dominant Leber Congenital Amaurosis (LCA)”
Free
We invite you to register and join us on November 15 from 11:00 am - 12:00 pm ET for a free NCI technology webinar. Attendees will hear from Drs. Anand Swaroop, Ph.D. and Kamil Kruczek, Ph.D. of the National Eye Institute about a new gene therapy method for treating CRX-autosomal dominant Leber Congenital Amaurosis (LCA). LCA is a rare genetic disease that is responsible for about 20% of all childhood blindness. It’s caused by mutations in any of at least 25…
Find out more »